Rank;Global Rank;Institution;Country;Sector
1;52;Novartis Farma, S.p.A., Italy;ITA;Companies
2;125;Philips Research Eindhoven;NLD;Companies
3;164;Merck KGaA, Germany;DEU;Companies
4;186;GlaxoSmithKline, Belgium;BEL;Companies
5;221;Hoffmann-La Roche, GmbH., Germany;DEU;Companies
6;226;AstraZeneca, United Kingdom;GBR;Companies
7;230;Novartis Institutes for Biomedical Research, Switzerland;CHE;Companies
8;232;IMEC International;BEL;Companies
9;236;Novartis, Switzerland;CHE;Companies
10;268;GlaxoSmithKline, United Kingdom;GBR;Companies
11;282;Siemens AG;DEU;Companies
12;305;Bayer AG Germany;DEU;Companies
13;337;Novo Nordisk A/S;DNK;Companies
14;355;France Telecom, S.A.;FRA;Companies
15;398;Bruker Corporation;DEU;Companies
16;438;BASF AG;DEU;Companies
17;452;Hoffmann-La Roche, Ltd., Switzerland;CHE;Companies
18;475;STMicroelectronics;ITA;Companies
19;492;Pfizer Inc., United Kingdom;GBR;Companies
20;504;Robert Bosch GmbH;DEU;Companies
21;507;VTT Technical Research Centre of Finland;FIN;Companies
22;690;Daimler AG;DEU;Companies
23;776;AstraZeneca, Sweden;SWE;Companies
24;801;SAP AG;DEU;Companies
25;861;AIRBUS Germany;DEU;Companies
26;1002;Thales Group France, S.A.;FRA;Companies
27;1088;STMicroelectronics;FRA;Companies
28;1125;Infineon Technologies;DEU;Companies
29;1374;Eli Lilly and Company Ltd., United Kingdom;GBR;Companies
30;1391;SINTEF Group;NOR;Companies
31;1587;Microsoft Research Cambridge;GBR;Companies
32;2075;Renault, S.A.S.;FRA;Companies
33;3052;Sincrotrone Trieste;ITA;Companies
34;3865;Electricite de France, S.A.;FRA;Companies
35;3964;Atomic Weapons Establishment;GBR;Companies
35;3964;Rolls-Royce plc;GBR;Companies